News|Articles|February 17, 2024

Global Use of Nonprescription Weight-Loss Products Among Adolescents: 5 Key Takeaways

What does recent research tell us about use of nonprescription weight-loss products among teens?

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

An Update on the Harms of Social Media on Teen Mental Health: Meta Settles for $18 Billion

ByLeah Kuntz

August 28th 2026

Patent Application Published: MDMA-N-Acylethanolamines for the Treatment of PTSD, Anxiety, and Eating Disorders

ByLeah Kuntz

August 24th 2026

Psychiatry and the Treatment of Stuttering: A Blossoming Partnership

ByMike Hennessy Jr

August 11th 2026

Interdisciplinary Consensus Guidelines on Stuttering (Childhood-Onset Fluency Disorder): Addressing Issues in Diagnosis, Treatment, and Unmet Needs

ByGerald A. Maguire, MD,Heidi Anne Duerr, MPH,Shahriar SheikhBahaei, PhD,Yoshikazu Kikuchi, MD, PhD,Lisa LaSalle PhD, CCC-SLP,Thomas J. Valente, MD,Anelise Junqueira Bohne, PhD, SLP,Tiago Proença dos Santos, MD,Gonçalo Leal, SLP,Devin Binder, MD, PhD,Gustavo Alva, MD, DFAPA,Greg Mattingly, MD

August 10th 2026

Unified Treatment Model Shows Long-Term Symptom Gains in BIPOC Patients With Eating Disorders

ByLeah Kuntz

July 31st 2026

Latest CME

In-Person Event

Jersey City Psychiatry

October 2-3, 2026

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Video

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

Global Use of Nonprescription Weight-Loss Products Among Adolescents: 5 Key Takeaways

Related Content

An Update on the Harms of Social Media on Teen Mental Health: Meta Settles for $18 Billion

Patent Application Published: MDMA-N-Acylethanolamines for the Treatment of PTSD, Anxiety, and Eating Disorders

Psychiatry and the Treatment of Stuttering: A Blossoming Partnership

Interdisciplinary Consensus Guidelines on Stuttering (Childhood-Onset Fluency Disorder): Addressing Issues in Diagnosis, Treatment, and Unmet Needs

Unified Treatment Model Shows Long-Term Symptom Gains in BIPOC Patients With Eating Disorders

Latest CME

Jersey City Psychiatry

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Trending on Psychiatric Times

Psychiatry on Trial: Are Psychiatrists Responsible for Their Patients’ Criminal Behavior?

Insanity Trials and The Court of Popular Opinion

Mindfully Prescribing Benzodiazepines in Psychiatry

Modified Titration Dosing Reduces ARIA-E Risk With Donanemab, A Discussion With John Sims, MD

Biomarker Testing for Alzheimer Disease: Inside the Latest P-Tau217 Data